We are live on
!
Find out more
IRC
Investors Research Corp Portfolio holdings
AUM
$559M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+5.75%
1 Year Est. Return
+21.55%
3 Year Est. Return
+57.22%
5 Year Est. Return
+62.75%
10 Year Est. Return
–
AUM
$162M
AUM Growth
–
Cap. Flow
+$158M
Cap. Flow
% of AUM
97.42%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
331
New
331
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$1.9M |
| 2 |
Intel
INTC
|
+$1.79M |
| 3 |
UFS
DOMTAR CORPORATION (New)
UFS
|
+$1.74M |
| 4 |
Capri Holdings
CPRI
|
+$1.57M |
| 5 |
Kelly Services Class A
KELYA
|
+$1.48M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.94% |
| 2 | Consumer Discretionary | 16.82% |
| 3 | Technology | 13.5% |
| 4 | Materials | 11.12% |
| 5 | Consumer Staples | 7.32% |
Similar funds
DIM
CFP
TCM
QL
NCA
CAM
MCM
FGAM
Investors Research Corp's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Investors Research Corp, which disclosed 331 positions worth $162M. Its ten largest holdings account for 9.9% of the portfolio.
Its largest position is DIPLOMAT PHARMACY, INC.: 96,550 shares worth $1.94M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, followed by Consumer Discretionary and Technology.
- Investors Research Corp's largest Q4 2017 buy was DIPLOMAT PHARMACY, INC.: 96,550 shares worth $1.94M.
- Investors Research Corp's ten largest holdings make up 9.9% of its $162M portfolio in Q4 2017.
- Investors Research Corp disclosed 331 positions in Q4 2017, its first 13F filing on record.
Based on Investors Research Corp's 13F filing for Q4 2017, filed 13 Feb 2018.